Catecholamines are endogenous amines that participate in the maintenance of cardiovascular system homeostasis. However, excessive release or exogenous administration of catecholamines is cardiotoxic. The synthetic catecholamine, isoprenaline (isoproterenol, ISO), with non-selective β-agonistic activity has been used as a viable model of acute myocardial toxicity for many years. Since the pathophysiology of ISO-cardiotoxicity is complex, the aim of this study was to elucidate the effect of oral quercetin pretreatment on myocardial ISO toxicity. Wistar-Han rats were randomly divided into four groups: solvent or quercetin administered orally by gavage in a dose of 10 mg kg(-1) daily for 7 days were followed by s.c. water for injection or ISO in a dose of 100 mg kg(-1). Haemodynamic, ECG and biochemical parameters were measured; effects on blood vessels and myocardial histology were assessed, and accompanying pharmacokinetic analysis was performed. Quercetin was unable to protect the cardiovascular system against acute ISO cardiotoxicity (stroke volume decrease, cardiac troponin T release, QRS-T junction elevation and histological impairment). The sole positive effect of quercetin on catecholamine-induced cardiotoxicity was the normalization of increased left ventricular end-diastolic pressure caused by ISO. Quercetin did not reverse the increased responsiveness of rat aorta to vasoconstriction in ISO-treated animals, but it decreased the same parameter in the control animals. Accompanying pharmacokinetic analysis showed absorption of quercetin and its metabolite 3-hydroxyphenylacetic acid formed by bacterial microflora. In conclusion, a daily oral dose of 10 mg kg(-1) of quercetin for 7 days did not ameliorate acute ISO-cardiovascular toxicity in rats despite minor positive cardiovascular effects.

Department of Pharmacology and Toxicology Faculty of Pharmacy in Hradec Králové Charles University Prague Heyrovského 1 203 Hradec Králové 500 05 Czech Republic

Zobrazit více v PubMed

Am J Clin Nutr. 2008 Oct;88(4):1018-25 PubMed

J Nutr. 2003 Sep;133(9):2802-7 PubMed

Eur J Pharmacol. 2011 Dec 5;671(1-3):95-101 PubMed

Can J Physiol Pharmacol. 1982 Nov;60(11):1390-7 PubMed

Circ Res. 1981 Jun;48(6 Pt 1):813-24 PubMed

Arzneimittelforschung. 1987 Jun;37(6):729-32 PubMed

AMA Arch Pathol. 1959 Apr;67(4):443-55 PubMed

Free Radic Res. 2010 Feb;44(2):224-31 PubMed

Curr Med Chem. 2011;18(15):2272-314 PubMed

Mol Cell Biochem. 1998 Oct;187(1-2):173-82 PubMed

Toxicol Pathol. 2010 Aug;38(5):703-14 PubMed

Med Lab Sci. 1990 Jan;47(1):10-6 PubMed

Biochem Pharmacol. 1989 Jun 1;38(11):1763-9 PubMed

J Cardiovasc Pharmacol. 2006 Apr;47(4):531-41 PubMed

J Nutr. 2008 Sep;138(9):1615-21 PubMed

J Biol Chem. 1981 Dec 10;256(23):12281-6 PubMed

Hum Exp Toxicol. 2009 Oct;28(10):631-40 PubMed

Mol Cell Biochem. 2006 Sep;289(1-2):125-36 PubMed

Food Funct. 2012 Jun;3(6):643-50 PubMed

Can J Physiol Pharmacol. 1997 Dec;75(12):1300-11 PubMed

J Clin Invest. 1976 Sep;58(3):751-60 PubMed

Life Sci. 2003 Dec 19;74(5):603-12 PubMed

Toxicology. 2009 Jan 8;255(1-2):25-32 PubMed

Mol Cell Endocrinol. 1984 Oct;37(3):245-56 PubMed

Am J Physiol. 1968 Jan;214(1):197-204 PubMed

Int J Clin Pharmacol Ther. 1999 May;37(5):219-33 PubMed

J Nutr. 2003 Jun;133(6):1806-14 PubMed

Br J Nutr. 2013 Jun;109(11):1923-33 PubMed

Can J Physiol Pharmacol. 2012 Apr;90(4):473-84 PubMed

J Cell Mol Med. 2007 Jan-Feb;11(1):156-70 PubMed

Hum Exp Toxicol. 2012 Aug;31(8):830-43 PubMed

Br J Nutr. 2009 Oct;102(7):1065-74 PubMed

Biol Pharm Bull. 2002 Feb;25(2):197-200 PubMed

Fundam Appl Toxicol. 1981 Nov-Dec;1(6):443-7 PubMed

Eur J Clin Pharmacol. 2000 Nov;56(8):545-53 PubMed

Int J Cardiol. 2011 Mar 3;147(2):191-201 PubMed

Eur J Pharmacol. 2010 Jun 10;635(1-3):142-8 PubMed

J Mol Cell Cardiol. 1985 Apr;17(4):291-306 PubMed

J Nutr. 1995 Jul;125(7):1911-22 PubMed

J Agric Food Chem. 2008 May 28;56(10):3609-15 PubMed

Atherosclerosis. 1981 Apr;39(1):71-87 PubMed

J Pharm Pharmacol. 2006 May;58(5):701-7 PubMed

Exp Mol Pathol. 2010 Apr;88(2):299-304 PubMed

J Nutr. 2007 Nov;137(11):2405-11 PubMed

Biomed Biochim Acta. 1985;44(11-12):1641-9 PubMed

Am J Pathol. 1989 Feb;134(2):365-71 PubMed

Fundam Clin Pharmacol. 2010 Oct;24(5):539-46 PubMed

J Biol Chem. 2007 Apr 13;282(15):11397-409 PubMed

J Nutr. 2008 Aug;138(8):1417-20 PubMed

Fitoterapia. 2011 Jun;82(4):513-23 PubMed

Comprehensive review of cardiovascular toxicity of drugs and related agents

Intravenous rutin in rat exacerbates isoprenaline-induced cardiotoxicity likely due to intracellular oxidative stress